Universities quietly negotiating with White House aide to try to avoid Harvard's fate, source says
The higher education leaders, who have had granular conversations with senior White House policy strategist May Mailman in recent weeks, are asking what signals they need to send to stay out of the administration's crosshairs, the person said. Mailman works closely with Miller – an architect of the administration's strategy to target colleges over concerns they are not sufficiently policing alleged antisemitism on their campuses.
In turn, a White House official said the administration is relaying to the leaders that 'the money simply cannot and will not flow unabated as it has been – and that the universities are incubators of discrimination and the taxpayer cannot support that.'
These conversations come as the administration is investigating dozens of other schools, and as some school leadership comes to Washington.
The White House is looking to strike a deal with a high-profile school, said the first source, who is involved in the higher education response.
'They want a name-brand university to make a deal like the law firms made a deal that covers not just antisemitism and protests, but DEI and intellectual diversity,' this person said.
'They want Trump to be able to stand up and say he made a deal with so-and-so – an Ivy League school, some sort of name-brand school that gives them cover so they can say, 'We don't want to destroy higher education.''
Asked if any of the schools are inclined to make such a deal, the source said, 'Nobody wants to be the first, but the financial pressures are getting real.'
Many schools have already experienced significant federal funding cuts, and there is mounting uncertainty about the future of visas for international students, who are more likely to pay full tuition compared to their American counterparts.
The conversations, the source said, are continuing.
'The President is always willing to make a deal that benefits America, and this has been true for any higher education institution willing to embrace common sense, stop violating the law, and commit to restoring civil rights and order on their campuses,' the White House official said.
They added, 'The administration is only willing to work with entities that operate in good faith and are not merely paying lip service without tangible actions. Many schools want to make a deal, and the President is willing to work with them.'
Officials at some other schools are waiting for the White House to turn its attention away from Harvard. A board member at a major university targeted by the task force, who was granted anonymity to speak freely, described communications as 'irregular,' but said there have been repeated efforts by the task force to get the school's leadership to come to Washington for a meeting.
'There is very little enthusiasm for that,' the board member said. 'We do not have any interest in being their 'model school' or whatever.'
They added, 'At this point, we feel very comfortable with the steps we've taken, and we don't have any need to fight the administration, per se – unless they decide to mess with our core values. When it comes, we will be ready to fight them. But that doesn't mean we need to provoke them.'
Some universities across the country have hired political consultants and experts to respond to some of the administration's demands, while Harvard has launched an aggressive legal strategy and is organizing its alumni networks.
Efforts to target Harvard began even before President Donald Trump returned to office, with Trump allies arguing they're cracking down on antisemitism on campus amid the Israel-Hamas war. But the administration's actions extend to a broader agenda – setting up a major clash over academic freedom, federal funding and campus oversight – and a belief inside the White House that it's a winning political issue for Trump.
The crackdown is led by the Task Force to Combat Anti-Semitism, an interagency group that meets at least weekly, the White House official said, and is in regular communication about where to train its focus. At the helm is former Fox News personality and civil rights lawyer-turned-senior Justice Department official Leo Terrell. Miller and Mailman are also driving forces behind decision making, sources said.
The administration has been happy with steps taken by some schools, praising some of its initial targets for complying with demands, including efforts to dismantle diversity, equity, and inclusion programs and crack down on campus protests.
And which schools the administration could go after next appears to be a moving target.
But Terrell suggested this week that 'massive lawsuits' are coming and would take aim at the University of California system, among others.
'Expect massive lawsuits against UC system. … On the East Coast, on the West Coast, in the Midwest, expect hate crime charges filed by the federal government. Expect Title VII lawsuits against those individuals who are not being protected simply because they're Jewish,' he told Fox News.
Asked for comment on Terrell's threats, Rachel Zaentz, a spokesperson for the University of California, said that the school system is cooperating with the Trump administration.
'The University of California abhors antisemitism and is diligently working to address, counter and eradicate it in all its forms across the system. We have been, and plan to continue, cooperating with the Administration. Antisemitism has no place at UC or anywhere else in society. The University remains entirely focused on strengthening our programs and policies to root out antisemitism and all forms of discrimination,' Zaentz said.
The White House official told CNN last month that the task force was having discussions with Harvard and Columbia, as well as Northwestern University, Cornell University and the University of Michigan.
A February Justice Department news release also identified George Washington University; Johns Hopkins University; New York University; the University of California, Berkeley; the University of Minnesota; and the University of Southern California as 'campuses that have experienced antisemitic incidents since October 2023' that the task force planned to visit.
University leaders have been coming to DC to meet with administration officials, so no campus visits have been necessary, according to a senior administration official.
CNN has reached out to each of the schools named by the Trump administration for comment. Statements from the University of Southern California and the University of Minnesota both denounced antisemitism and said the schools would engage with the task force on efforts to combat it.
Pressed on how the task force is making determinations about funding for Harvard and other schools, the White House official said that their investigations often begin with complaints.
'The relevant agency or department will conduct an investigation into violations to federal law, whether Title IV and Title IX, Title VI, Title XI, Title XII, and, based on those investigations, there can be immediate action to pause funding and wait for a resolution to the investigation, or, in more egregious examples, like Harvard, there could just be a blanket removal of all federal funds because of their lack of cooperation in an investigation or their blatant disregard for their violations to federal law and their unwillingness to change policy,' the official said.
And the senior administration official indicated this week that any school with an open Title VI investigation could be subject to government action. Title VI is part of the Civil Rights Act of 1964 prohibiting discrimination based on race, color or national origin in programs or activities receiving federal funding. There are more than 70 colleges and universities currently under active Title VI investigations as of Wednesday, according to a CNN analysis of data provided by the Department of Education. (A vast majority of those investigations were launched during the Biden administration.)
And even as it looks at other schools, the administration hasn't taken its eye off Harvard, with which it's engaged in multiple legal battles.
The administration has also launched an investigation into its foreign funding sources through a provision of the Higher Education Act requiring reporting of foreign gifts and contracts called Section 117. A prior Section 117 investigation into Harvard was recently closed.
'As standard practice, Harvard has filed Section 117 reports for decades as part of its ongoing compliance with the law. As is required, Harvard's reports include information on gifts and contracts from foreign sources exceeding $250K annually. This includes contracts to provide executive education, other training, and academic publications,' Jason Newton, a spokesperson for Harvard University, said in a statement, noting that Harvard's filings reflect 'diverse sources' of support for the school.
And a tax provision in Trump's 'one big, beautiful bill,' which passed the House of Representatives last week but still has to get through the Senate, could have significant impact on Harvard and other institutions with large endowments. In its current form, it would implement a new 'tiered system' of taxes on private colleges and universities' investment income. The endowment tax is currently a flat 1.4% rate but could become as high as 21% for schools like Harvard with large endowments.
The administration believes there's political support for that provision, with Education Secretary Linda McMahon telling Fox News on Wednesday, 'That's something that the American public could wrap its head around.'
Trump administration messengers have offered mixed signals about how the process moves forward.
The source familiar with the higher education response questioned the appetite to proceed at an aggressive pace.
'If you go after Harvard, how hard can you keep going? The universities are being played like a yo-yo for weeks and weeks and weeks. My guess is, at some point, the White House will lose interest in that. Once you've taken down Harvard, where are you going to go – Emory? They're just as conscious of the brands as anybody else,' the source said.
Ultimately, the source added, the market rules: 'What's going to happen to Harvard or Columbia? Record applicants, record yield. I would bet you that if you talked to MAGA voters at Charlotte Country Day School or The Westminster Schools – they may have voted for Trump, but are they turning away from the Ivy League? Hell no. The schools are having record demand.'
Meanwhile, McMahon has suggested there is still hope for negotiations with Harvard, with whom the senior administration official said the administration is not currently in talks.
'We really hope that we will be back at the table, negotiating, talking about the things that are good for Harvard and for the students that are on campus,' McMahon said.
Terrell has struck a different tone.
'We are going to go after them where it hurts them financially, and there's numerous ways – I hope you can read between the lines – there's numerous ways to hurt them financially,' he warned on Fox News.
Asked when it would end, Terrell said, 'We can't speculate. We have to bring these universities to their knees.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Got $1,000? 2 High-Yield Healthcare Stocks to Buy and Hold Forever
Key Points The average healthcare stock is yielding a fairly modest 1.8% these days. Medtronic has a historically high yield and a long history of raising its dividend. Alexandria Real Estate's yield is ultra-high, and it has plenty of dividend coverage. 10 stocks we like better than Medtronic › The average healthcare stock has a yield of just 1.8%, which isn't much to write home about today. You can do much better than that with Medtronic (NYSE: MDT), currently yielding 3%, or if you're really income-hungry, Alexandria Real Estate Equities (NYSE: ARE), now at 6.9%. Here's why these two high-yield healthcare stocks could be buy-and-hold candidates for your income portfolio right now. Medtronic is moving in the right direction A $1,000 investment in Medtronic will get you around 10 shares of the medical device giant. It has operations in the cardiovascular, neuroscience, medical-surgical, and diabetes arenas, and is a major player in every niche in which it operates. It also has a long history of success that's highlighted by the company's 48-year streak of annual dividend increases, which puts it just two years away from Dividend King status. That dividend streak is really important because it shows that Medtronic knows how to survive through both good and bad times. Indeed, a company can't create a record like that without having successfully muddled through a few rough patches. The 3% dividend yield is historically high today, which signals that Medtronic is going through another rough patch. What's happening right now, however, isn't unusual. Medtronic's business is heavily dependent on research and development. R&D is notoriously lumpy, and recent years haven't been great for new product launches. But new products are starting to get introduced, which should help boost growth. Meanwhile, costs have become an issue. It's normal for a large company to experience bloat, and Medtronic is looking to slim down and refocus around its most profitable businesses; the next big move is the spinoff of its diabetes business in 2026. The move is expected to be accretive in the first year, highlighting management's focus on profitability. In other words, Medtronic is doing what it should be doing -- and that is what it has long done as a business. If you have a buy-and-hold mentality, putting $1,000 to work in Medtronic today could be a great long-term investment choice. Alexandria is an industry-leading healthcare landlord You can buy around 12 shares of Alexandria Real Estate Equities with $1,000. It's a real estate investment trust (REIT) that focuses on owning medical offices. But that description doesn't do it justice, because those medical offices are highly specialized around medical research. They're vastly different from doctors' offices, given the technology needed to support healthcare research and development. Alexandria has long focused on building clusters -- a number of buildings located near each other -- in areas where medical research is a major industry. That helps with costs, and also helped to solidify the REIT as a leading property owner in its chosen niche. That said, Alexandria is in a bit of a transition period right now, as it looks to slim down to its best assets amid a broader slowdown in the medical-office space. A few large move-outs have also hampered results, with occupancy down to roughly 91% at the end of the second quarter of 2025, from about 95% at the end of 2024. Investors are worried, which isn't unreasonable, since adjusted funds from operations (FFO) per share fell slightly year over year in the second quarter. Still, the $2.33 per share in adjusted FFO is more than enough to cover the $1.32 per share in quarterly dividends. While it's true that office space requires more cash investment than many other property types, there is material leeway for adversity for Alexandria. And given that the dividend has been increased annually for 15 straight years, it seems highly likely that the board will look to support the dividend through this weak patch. Note, too, that the balance sheet is in very strong shape and the company doesn't have any material near-term debt maturities on the horizon. If you don't mind buying when others are fearful, this REIT looks like an attractive income opportunity. The right time to buy is often the hard time to buy It's easy to buy stocks that everybody loves, but just following the crowd can lead to bad investment choices. That's why it often pays to go down a less crowded path, buying well-run businesses when they're facing hard times. That's exactly the case with both Medtronic and Alexandria Real Estate Equities today. History suggests that both have a good chance of breaking out of their current funk. And that makes them strong buy-and-hold investment choices for long-term dividend investors. Should you buy stock in Medtronic right now? Before you buy stock in Medtronic, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Medtronic wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $654,781!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,076,588!* Now, it's worth noting Stock Advisor's total average return is 1,055% — a market-crushing outperformance compared to 183% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 18, 2025 Reuben Gregg Brewer has positions in Medtronic. The Motley Fool has positions in and recommends Alexandria Real Estate Equities. The Motley Fool recommends Medtronic and recommends the following options: long January 2026 $75 calls on Medtronic and short January 2026 $85 calls on Medtronic. The Motley Fool has a disclosure policy. Got $1,000? 2 High-Yield Healthcare Stocks to Buy and Hold Forever was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
26 minutes ago
- Yahoo
Post Malone apart of new SKIMS campaign
Post Malone has joined SKIMS, with founder Kim Kardashian describing the partnership as a "perfect fit".
Yahoo
26 minutes ago
- Yahoo
Downsize me: McDonald's plans to cut combo meal prices after complaints
McDonald's is slashing its combo meal prices after customers had a beef with the burger giant's rising prices. For eight popular combo meals, the fast-food chain will offer prices 15 percent below the sum of the items sold separately, the Wall Street Journal first reported. A combo meal that now costs $10 could soon cost $8.50. 'Customers are telling us they need more of the everyday value and affordability that defines the McDonald's brand,' Joe Erlinger, president of McDonald's USA, told the company after it released a quarterly report this month, according to the outlet. Customers will see the changes as soon as this fall. In September, McDonald's will offer $5 Sausage Egg McMuffin and $8 Big Mac meals; in November, Sausage, Egg and Cheese McGriddle and 10-piece Chicken McNuggets meals will go for $5 and $8. To add to the delicious new prices, McDonald's is reintroducing the 'Extra Value Meals' branding, which includes $5 breakfast and $8 Big Mac and McNugget combo-meal specials, the Journal reported. The chain first launched 'Extra Value Meals' — bargain combo meals — in 1991, but stopped marketing them as such during the Covid-19 pandemic, the outlet reported. The Independent has asked McDonald's for more information. The move comes amid complaints from customers about the fast-food chain's rising prices. A viral 2023 tweet showed a Big Mac combo meal costing nearly $18, rocking the internet. The company called that price tag 'an exception' but the complaints have continued to roll in across social media. 'McDonald's used to be the escape when rent was due and payday was far, one X user groaned earlier this month. 'Now a 'value meal' is $14 and the value is gone…When people can't even afford McDonald's, the economy is already broken.' Another reminisced last week: 'Remember when McDonald's used to be cheap?' Yet another expressed disappointment, writing this month: 'How is a medium french fry at McDonald's $3.39? Geez, that's ridiculous.' '$26.60 for a breakfast for two at McDonald's?' another wrote, adding 16 question marks. 'INSANITY!!! This is Trump and Elon's America!' While President Donald Trump and his former head of the Department of Government Efficiency may not be entirely to blame for the climbing prices, McDonald's first quarter earnings report showed a dip in sales, which fast-food chain executives chalked up to 'economic uncertainty.' Sales grew during the second quarter, but the fast-food giant noticed a decline in low-income diners. "There is a lot of anxiety and unease with that low-income consumer," Kempczinski said during a call this month, citing tariffs and a slowdown in real income growth. 'The single biggest driver of what shapes a consumer's overall perception of McDonald's value is the menu board,' he added. McDonald's combo meals priced at $10 or more could be deterring lower-income customers. The average large Big Mac meal costs $10.53, according to The Journal. But that price tag depends on the location, with the prices range from $5.69 to $18.99, according to data seen by the outlet from market-research firm Technomic. To help appeal to these customers, the chain debuted a new $5 meal deal last as part of its 'McValue' menu. McDonald's CFO Ian Borden at the time attributed the deal as driving traffic 'particularly with low-income consumers, successfully growing traffic share with this group for the first time in over a year."